The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics ...

With current market conditions and intensifying societal needs, today’s healthtech founders have a chance to truly transform ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Former DeepMind scientist Simon Kohl has raised $50 million for Latent Labs, a London-based AI startup aiming to transform ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

A new startup founded by a former Google DeepMind scientist is exiting stealth with $50 million in funding. Latent Labs is ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...